AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

RoboStrategy, Inc. Common Stock

$26.85 -$12.15 (-31.15%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$27.5
Day Range
$26.35$27.77
Year Range
$19.2$59
Market Cap
544.36M
AVG Volume
623.62K
Trailing/Forward PE
-/-
PEG ratio
-
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
NASDAQUS
RoboStrategy, Inc. Common Stock
BOT
Stockpicker

Video analysis: BOT

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BOT

RoboStrategy, Inc. Updates Net Asset Value as of August 31, 2026

globenewswire.com · 2 Sep 2026

RoboStrategy, Inc. Updates Net Asset Value as of August 31, 2026

NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- RoboStrategy, Inc. (Nasdaq: BOT), a registered closed end fund providing exposure to private companies in robotics and physical AI, today announced its net asset value per share as of August 31, 2026.

Agenus Announces Peer-Reviewed Publication Linking BOT+BAL's Durable Survival in MSS Metastatic Colorectal Cancer to Its Distinct Immune-Priming Mechanism

gurufocus.com · 28 Aug 2026

Agenus Announces Peer-Reviewed Publication Linking BOT+BAL's Durable Survival in MSS Metastatic Colorectal Cancer to Its Distinct Immune-Priming Mechanism

[url="]Agenus[/url] Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the peer-reviewed publication of mature Phase 1b results from t

Agenus Announces Updated NEST Phase 2 Publication Reporting Deep Pathologic Responses and No Observed Recurrences with Neoadjuvant BOT+BAL in Resectable Colon Cancer

gurufocus.com · 26 Aug 2026

Agenus Announces Updated NEST Phase 2 Publication Reporting Deep Pathologic Responses and No Observed Recurrences with Neoadjuvant BOT+BAL in Resectable Colon Cancer

[url="]Agenus[/url] Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the peer-reviewed publication of updated results from the inves

RoboStrategy, Inc. Releases First Shareholder Letter

globenewswire.com · 24 Aug 2026

RoboStrategy, Inc. Releases First Shareholder Letter

NEW YORK, Aug. 24, 2026 (GLOBE NEWSWIRE) -- RoboStrategy, Inc. (Nasdaq: BOT), a registered closed end fund providing exposure to private companies in robotics and physical AI, today released its first shareholder letter, on the Company's website at https://robostrategy.co/news/shareholder-letter-aug-2026.

RoboStrategy, Inc. Updates Net Asset Value as of July 31, 2026

globenewswire.com · 12 Aug 2026

RoboStrategy, Inc. Updates Net Asset Value as of July 31, 2026

NEW YORK, Aug. 12, 2026 (GLOBE NEWSWIRE) -- RoboStrategy, Inc. (Nasdaq: BOT), a registered closed-end fund providing exposure to private companies in robotics and physical AI, today announced its net asset value per share as of July 31, 2026.

RoboStrategy, Inc. Raises Approximately $16.0 Million Through Private Share Issuances, Including $10.0 Million Investment by CEO Andrew Kang

globenewswire.com · 15 Jul 2026

RoboStrategy, Inc. Raises Approximately $16.0 Million Through Private Share Issuances, Including $10.0 Million Investment by CEO Andrew Kang

Fund completes private placements with institutional investors and its Founder and CEO between July 7 and July 14, 2026 Fund completes private placements with institutional investors and its Founder and CEO between July 7 and July 14, 2026

RoboStrategy, Inc. Announces Updated Net Asset Value and Additional Private Placements

globenewswire.com · 8 Jul 2026

RoboStrategy, Inc. Announces Updated Net Asset Value and Additional Private Placements

Fund updates net asset value as of June 30, 2026, and completes approximately $7.6 million in additional private share issuances Fund updates net asset value as of June 30, 2026, and completes approximately $7.6 million in additional private share issuances

RoboStrategy, Inc. Raises Approximately $33.9 Million Through Private Share Issuances

globenewswire.com · 29 Jun 2026

RoboStrategy, Inc. Raises Approximately $33.9 Million Through Private Share Issuances

Fund completes private placements with institutional investors between June 26 and June 29, 2026 Fund completes private placements with institutional investors between June 26 and June 29, 2026

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.